Cargando…

Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BACKGROUND: The study investigated the predictive value of tumor angiogenesis observed by (18)F-ALF-NOTA-PRGD2 II (denoted as (18)F-Alfatide II) positron emission tomography (PET)/computed tomography (CT) before concurrent chemoradiotherapy (CCRT) for treatment response and survival among patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yuchun, Qin, Xueting, Liu, Xiaoli, Zheng, Jinsong, Luan, Xiaohui, Zhou, Yue, Yu, Jinming, Yuan, Shuanghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811991/ https://www.ncbi.nlm.nih.gov/pubmed/35109866 http://dx.doi.org/10.1186/s12967-022-03256-3

Ejemplares similares

(18)F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
por: Luan, Xiaohui, et al.
Publicado: (2016)

A Pilot Study of (18)F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer
por: Zhou, Yue, et al.
Publicado: (2017)

Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model
por: Wei, Yu-Chun, et al.
Publicado: (2016)

(18)F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
por: Li, Li, et al.
Publicado: (2020)

[(18)F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer
por: Wei, Yuchun, et al.
Publicado: (2021)

Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers (18)F-Alfatide and (18)F-FDG: A Comparative Analysis
por: Wei, Yu-Chun, et al.
Publicado: (2015)

Comparing the Differential Diagnostic Values of (18)F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients
por: Du, Xiaoqing, et al.
Publicado: (2018)

Longitudinal PET Imaging of Muscular Inflammation Using( 18)F-DPA-714 and (18)F-Alfatide II and Differentiation with Tumors
por: Wu, Chenxi, et al.
Publicado: (2014)

Diagnostic Value of (18)F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
por: Qin, Xueting, et al.
Publicado: (2022)

Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases
por: Mi, Baoming, et al.
Publicado: (2015)

Prognosis Evaluation Using (18)F-Alfatide II PET in a Rat Model of Spinal Cord Injury Treated With Estrogen
por: Tan, Hongpei, et al.
Publicado: (2020)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

Fluorine-18 labeled amino acids for tumor PET/CT imaging
por: Qi, Yiqiang, et al.
Publicado: (2017)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Potential (18)F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy
por: Li, Li, et al.
Publicado: (2022)

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
por: Deantonio, Letizia, et al.
Publicado: (2018)

Recurrence patterns are significantly associated with the (18)F‑FDG PET/CT radiomic features of patients with locally advanced non‑small cell lung cancer treated with chemoradiotherapy
por: Liu, Wenju, et al.
Publicado: (2023)

Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma
por: Liu, Changmin, et al.
Publicado: (2020)

Effects of cigarette smoking on metabolic activity of lung cancer on baseline (18)F-FDG PET/CT
por: Jiang, Maoqing, et al.
Publicado: (2022)

Value of (18)F-FDG PET/CT for Assessment of Advanced Lacrimal Sac Non-Keratinizing Squamous Cell Carcinoma Successfully Treated with Concurrent Chemoradiotherapy
por: Liao, Ching-Yu, et al.
Publicado: (2021)

Hypoxia with (18)F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography ((18)F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome
por: Hu, Man, et al.
Publicado: (2019)

Use CT Imaging to Predict the Short-Term Outcome of Concurrent Chemoradiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
por: Cao, Xiaolan, et al.
Publicado: (2019)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2011)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer
por: Liu, Chao, et al.
Publicado: (2022)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

Combined pretreatment with (18)F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial
por: Ji, Shengjun, et al.
Publicado: (2018)

Can (18)F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study
por: Liu, Yachao, et al.
Publicado: (2023)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Predictive Value of (18)F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
por: Yoo, Jang, et al.
Publicado: (2022)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

Bronchopleural Fistula After Concurrent Chemoradiotherapy
por: van de Pas, Jorien M., et al.
Publicado: (2020)

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
por: Li, Li, et al.
Publicado: (2022)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

PET/CT planning during chemoradiotherapy for esophageal cancer
por: Seol, Ki Ho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5u2eqs9gcbmpbm6lu12v70d0nd